You searched for "regenerative"

1465 results found

Who will benefit from cataract surgery?

The need for cataract surgery is expected to rise dramatically in the future due to the increasing proportion of elderly citizens and increasing demands for optimum visual function. The aim of this study was to provide an evidence-based recommendation for...

Improved suppression after surgery for intermittent exotropia

This study aimed to investigate the clinical factors associated with the recovery from suppression, with successful postoperative target motor alignment in 237 patients with intermittent exotropia. Mean age at surgery was 8.2 ±3.2 years and 48.5% were male. Preoperative angle...

RCT of unilateral vs bilateral surgery for lateral incomitance in exotropia

The purpose of this study was to evaluate and compare the surgical outcomes in the management of lateral incomitance with regard to ocular alignment and change in lateral incomitance in cases of bilateral vs. unilateral strabismus surgery. This was a...

Hot debates in medical retina and imaging: Perspectives from the Controversies in Ophthalmology 2020 virtual conference

Controversies in medical retina and imaging were debated during the Controversies in Ophthalmology 2020 virtual conference held during two mid-day scientific sessions on 27 and 28 March 2020. The author recounts key perspectives and presents viewpoint recommendations from the Vision...

How much money is wasted on tests prior to cataract surgery? And why?

For routine cataract surgery, numerous studies have found that preoperative testing does not contribute usefully to safety or surgical success. Despite such guidelines, tests ordered for patients prior to phacoemulsification in the US remains high. To quantify the associated costs,...

RCOphth 2024 Preview

Here is our annual highlights preview of the upcoming RCOphth 2024 Annual Congress in Belfast's ICC, 20-23 May.

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Glaucoma: 30 years on

Back in 1993, the late and great Barry Cullen FRCS (Cavan born, Dublin trained), the first editor of Eye News, asked me to write an article about the current treatment of chronic open angle glaucoma (COAG). At the time I...

Fight for Sight continues to promote eye research

Eye research charity Fight for Sight has announced its latest project funding and its plans for continuing its efforts to advance eye research in the current global health crisis and beyond.

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Efficacy and safety of novel PF brimonidine / timolol fixed-combination ophthalmic solution for OAG

This study is a multicentre, randomised, open-label, parallel-group clinical trial to evaluate the efficacy and safety of a newly developed preservative-free (PF) brimonidine / timolol fixed-combination (BTFC) ophthalmic solutions as compared with preservative-containing (PC) BTFC ophthalmic solution in adult patients...

Newmedica calls for transparency over glaucoma waiting lists and more collaboration with community optometrists

Ophthalmology provider Newmedica is calling for greater transparency by all providers over glaucoma waiting lists to tackle a ‘postcode lottery’ facing patients. Coinciding with Glaucoma Awareness Week (30 June – 6 July), Newmedica, which provides NHS and private ophthalmology services,...